跳至主要内容
临床试验/CTRI/2015/03/005605
CTRI/2015/03/005605招募中不适用

A study to measure the natural cancer killing activity with the help of cell kill assay (CKA) in human granulocytes and determine effector mechanism of anti-cancer response of human granulocytes

Munogenics Inc1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2014年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
The stratify cohort of healthy volunteers and cancer patients as per cancer killing activity (%) (Both CKA1 and CKA 2).

研究概览

简要总结

The proposed study is an“intention to treat†protocol and aims to determine and correlate cancerkilling activity with effector mechanisms of human granulocytes of normalhealthy individuals, as compared to the control population (cancer patients).

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • •Inclusion: -Age between 18 and 40 years.
  • •Must be willing to undergo the CKA test and sign a written Informed consent document.
  • •Normal healthy volunteers (Pulse – between 50 and 100 / minute with no irregularities, Blood Pressure – Systolic 100- 180 mm Hg and Diastolic 50- 100 mm Hg, oral temperature not exceeding 37.50C, body weight –not less than 45 kg) -Should be in a healthy state of mind and body.
  • •For cancer patients -Male and female cancer patients >18 years of age with histologically or cytologically confirmed solid malignant tumors and willing to sign a written informed consent document.

排除标准

  • •Exclusion: -Must not have any known major illnesses in the past.
  • •Past 48 hours – Not taken any antibiotics or any other medications (Allopathic or Ayurveda or Sidha or Homeo).
  • •Past 24 hours – Not taken alcoholic beverages.
  • •Present – Not suffering from cough, influenza or sore throat, common cold.
  • •Women should not be pregnant or breast feeding her child.
  • •For cancer patients -Uncontrolled diabetes mellitus, recent significant cardiac disease or active serious infection, evidence of brain tumors or brain metastases at the time of screening, known HIV infection, recent use (within 30 days) of immunosuppressive agents other than steroids, prior history of stem cell transplantation and prior history of fludarabine therapy.

结局指标

主要结局

The stratify cohort of healthy volunteers and cancer patients as per cancer killing activity (%) (Both CKA1 and CKA 2).

时间窗: At baseline.

次要结局

  • •Correlation of markers of cytolysis/ necrosis produced by granulocytes with cancer cell kill in both cohorts.(•Correlation of expression of markers of apoptosis (cleaved caspase 3) by granulocytes for causing apoptosis of cancer cells in both cohorts.)

研究者

发起方
Munogenics Inc
申办方类型
Research institution

研究点 (1)

Loading locations...

相似试验